NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the “Class Period”), of the important October 28, 2024 lead plaintiff deadline. SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Terran Orbital Corporation (NYSE: LLAP) between August 15, 2023 and August 14, 2024, both dates inclusive (the “Class Period”), of the important November 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Terran securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024, both dates inclusive (the “Class Period”), of the important November 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased AMMO securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT T ...

NEW YORK, Oct. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iris Energy Limited (NASDAQ: IREN) between June 20, 2023 and July 11, 2024, both dates inclusive (the "Class Period"), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased Iris Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

NEW YORK, Oct. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bumble Inc. (NASDAQ: BMBL) between November 7, 2023 and August 7, 2024, both dates inclusive (the "Class Period"), of the important November 25, 2024 lead plaintiff deadline. SO WHAT: If you purchased Bumble securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

文章核心观点 - 根据诉讼,公司在2024年1月25日至2024年7月24日期间做出了虚假和/或误导性陈述,并/或未能披露:(1)与先前的陈述相反,公司汽车和工业领域的需求在2024年上半年继续下降;(2)因此,公司的收入和毛利率也在此期间持续下降;(3)因此,公司的公开声明在所有相关时期都存在重大虚假和误导性 [4] 公司概况 - 公司名称为STMicroelectronics N.V.(纽约证券交易所代码:STM) [1] - 公司是一家全球性的投资者权利法律公司,提醒2024年1月25日至2024年7月24日期间购买公司证券的投资者 [1] 诉讼相关 - 如果您在该期间购买了公司证券,您可能有权获得赔偿,而无需支付任何实际费用或成本,这是通过或有费用安排实现的 [1] - 如果您希望担任首席原告,您必须在2024年10月22日之前向法院提出申请 [2] - 原告代表团代表其他团体成员指导诉讼 [2] 律所介绍 - 该律所代表全球投资者,专注于证券集体诉讼和股东衍生诉讼 [3] - 该律所曾获得针对中国公司的最大证券集体诉讼和解 [3] - 该律所在2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一 [3] - 该律所自2013年以来一直位列前四名,并为投资者收回了数亿美元 [3] - 2019年,该律所单独为投资者获得了4.38亿美元的和解 [3] - 2020年,创始合伙人Laurence Rosen被Law360评为原告律师界的泰坦 [3]

文章核心观点 - 根据诉讼,公司在2024年2月6日至2024年7月24日期间(即"Class Period")向投资者提供了关于公司预期2024财年收入的重大信息,尤其是与公司核心产品经导管主动脉瓣膜置换(TAVR)业务的增长相关的信息 [1][4] - 公司声明包括对TAVR平台的强烈承诺、有信心通过扩大各种患者激活活动来获得未经治疗患者群体、以及持续声称在渗透率较低的市场存在重大需求 [4] - 当真实情况进入市场时,投资者遭受损失 [4] 根据相关目录分别进行总结 公司概况 - 公司名称为Edwards Lifesciences Corporation,股票代码为NYSE: EW [1] 诉讼相关 - 罗森律师事务所代表2024年2月6日至2024年7月24日期间购买公司证券的投资者提起集体诉讼 [1][2] - 如果投资者希望担任首席原告,必须在2024年12月13日之前向法院提出申请 [2] - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面拥有丰富经验,曾获得针对中国公司的最大规模证券集体诉讼和解 [3] 投资者损失 - 当真实情况进入市场时,投资者遭受损失 [4]

NEW YORK, Oct. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iLearningEngines, Inc. (NASDAQ: AILE) between April 22, 2024 and August 28, 2024, both dates inclusive (the "Class Period"), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased iLearningEngines securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

文章核心观点 - 公司Endava plc(纽交所代码:DAVA)在2023年5月23日至2024年2月28日期间的证券交易存在潜在问题 [1][3] - 投资者可能有权获得赔偿,无需支付任何费用或成本 [1] - 投资者可以在2024年10月25日之前申请成为集体诉讼的代表原告 [1][3] 公司情况总结 - 公司Endava plc是一家IT服务公司,主要为客户提供软件开发和数字转型服务 [1][3] - 公司在2023年5月23日至2024年2月28日期间存在潜在的虚假或误导性陈述,导致投资者遭受损失 [3] - 公司声称客户需求下降、延迟或取消项目,从而对2023财年和2024财年的收入及盈利产生不利影响 [3]

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the "Class Period"), of the important November 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased Allarity securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...